142 related articles for article (PubMed ID: 9796058)
21. Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres.
Tabata Y; Inoue Y; Ikada Y
Vaccine; 1996 Dec; 14(17-18):1677-85. PubMed ID: 9032899
[TBL] [Abstract][Full Text] [Related]
22. Induction of systemic and mucosal immune response in cattle by intranasal administration of pig serum albumin in alginate microparticles.
Rebelatto MC; Guimond P; Bowersock TL; HogenEsch H
Vet Immunol Immunopathol; 2001 Nov; 83(1-2):93-105. PubMed ID: 11604164
[TBL] [Abstract][Full Text] [Related]
23. Oral vaccine models: multiple delivery systems employing tetanus toxoid.
Jackson RJ; Staats HF; Xu-Amano J; Takahashi I; Kiyono H; Hudson ME; Gilley RM; Chatfield SN; McGhee JR
Ann N Y Acad Sci; 1994 Aug; 730():217-34. PubMed ID: 8080173
[TBL] [Abstract][Full Text] [Related]
24. Systemic administration of RANKL overcomes the bottleneck of oral vaccine delivery through microfold cells in ileum.
Maharjan S; Singh B; Jiang T; Yoon SY; Li HS; Kim G; Gu MJ; Kim SJ; Park OJ; Han SH; Kang SK; Yun CH; Choi YJ; Cho CS
Biomaterials; 2016 Apr; 84():286-300. PubMed ID: 26851393
[TBL] [Abstract][Full Text] [Related]
25. Comparison of murine nasal-associated lymphoid tissue and Peyer's patches.
Heritage PL; Underdown BJ; Arsenault AL; Snider DP; McDermott MR
Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1256-62. PubMed ID: 9351630
[TBL] [Abstract][Full Text] [Related]
26. A modified cholera holotoxin CT-E29H enhances systemic and mucosal immune responses to recombinant Norwalk virus-virus like particle vaccine.
Periwal SB; Kourie KR; Ramachandaran N; Blakeney SJ; DeBruin S; Zhu D; Zamb TJ; Smith L; Udem S; Eldridge JH; Shroff KE; Reilly PA
Vaccine; 2003 Jan; 21(5-6):376-85. PubMed ID: 12531635
[TBL] [Abstract][Full Text] [Related]
27. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice.
Strindelius L; Filler M; Sjöholm I
Vaccine; 2004 Sep; 22(27-28):3797-808. PubMed ID: 15315861
[TBL] [Abstract][Full Text] [Related]
28. Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizations.
Vajdy M; Singh M; Ugozzoli M; Briones M; Soenawan E; Cuadra L; Kazzaz J; Ruggiero P; Peppoloni S; Norelli F; del Giudice G; O'Hagan D
Immunology; 2003 Sep; 110(1):86-94. PubMed ID: 12941145
[TBL] [Abstract][Full Text] [Related]
29. CD19-deficient mice exhibit poor responsiveness to oral immunization despite evidence of unaltered total IgA levels, germinal centers and IgA-isotype switching in Peyer's patches.
Gärdby E; Lycke NY
Eur J Immunol; 2000 Jul; 30(7):1861-71. PubMed ID: 10940875
[TBL] [Abstract][Full Text] [Related]
30. Targeting lymphocyte Peyer's patch adhesion molecule-1: a relay approach to gut immunization.
McKenzie BS; Corbett AJ; Brady JL; Boyle JS; Rockman SP; Lew AM
Vaccine; 2005 May; 23(28):3668-78. PubMed ID: 15882527
[TBL] [Abstract][Full Text] [Related]
31. Sensitisation of gut-associated lymphoid tissue during oral immunisation.
Clancy R; Pucci A
Aust J Exp Biol Med Sci; 1978 Jun; 56(3):337-40. PubMed ID: 708323
[TBL] [Abstract][Full Text] [Related]
32. Biodegradable microspheres II: Immune response to a heterologous and an autologous protein entrapped in polyacryl starch microparticles.
Artursson P; Edman P; Sjöholm I
J Pharmacol Exp Ther; 1985 Jul; 234(1):255-60. PubMed ID: 3874284
[TBL] [Abstract][Full Text] [Related]
33. Biodegradable microspheres. III: some immunological properties of polyacryl starch microparticles.
Artursson P; Mårtensson IL; Sjöholm I
J Pharm Sci; 1986 Jul; 75(7):697-701. PubMed ID: 3489834
[TBL] [Abstract][Full Text] [Related]
34. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles.
Maloy KJ; Donachie AM; O'Hagan DT; Mowat AM
Immunology; 1994 Apr; 81(4):661-7. PubMed ID: 7518802
[TBL] [Abstract][Full Text] [Related]
35. Enhanced paracellular delivery of vaccine by hydrogel microparticles-mediated reversible tight junction opening for effective oral immunization.
Chen XY; Butt AM; Mohd Amin MCI
J Control Release; 2019 Oct; 311-312():50-64. PubMed ID: 31465827
[TBL] [Abstract][Full Text] [Related]
36. Biodegradable microspheres. XVIII: The adjuvant effect of polyacryl starch microparticles with conjugated human serum albumin.
Degling L; Stjärnkvist P
Vaccine; 1995 May; 13(7):629-36. PubMed ID: 7545343
[TBL] [Abstract][Full Text] [Related]
37. Induction of antibody-secreting cells and T-helper and memory cells in murine nasal lymphoid tissue.
Wu HY; Nikolova EB; Beagley KW; Russell MW
Immunology; 1996 Aug; 88(4):493-500. PubMed ID: 8881748
[TBL] [Abstract][Full Text] [Related]
38. Per-oral immunization with antigen-conjugated nanoparticles followed by sub-cutaneous boosting immunization induces long-lasting mucosal and systemic antibody responses in mice.
Howe SE; Konjufca VH
PLoS One; 2015; 10(2):e0118067. PubMed ID: 25710518
[TBL] [Abstract][Full Text] [Related]
39. Oral immunization with poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres containing pneumotropic bacterial antigens.
Kofler N; Ruedl C; Rieser C; Wick G; Wolf H
Int Arch Allergy Immunol; 1997 Aug; 113(4):424-31. PubMed ID: 9250588
[TBL] [Abstract][Full Text] [Related]
40. Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue.
Hagiwara Y; McGhee JR; Fujihashi K; Kobayashi R; Yoshino N; Kataoka K; Etani Y; Kweon MN; Tamura S; Kurata T; Takeda Y; Kiyono H; Fujihashi K
J Immunol; 2003 Feb; 170(4):1754-62. PubMed ID: 12574339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
